Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Semin Arthritis Rheum. 2013 Dec 4;43(6):778–783. doi: 10.1016/j.semarthrit.2013.11.011

Table 3.

The hazards model of treatment resistance, early ESRD, ESRD over entire follow-up, renal relapse, and death controlling with age, gender, race, creatinine at biopsy, and p-ANCA/MPO, c-ANCA/PR3

Treatment resistance (odds ratio) ESRD ever (hazard ratio) Early ESRD (hazard ratio) Renal relapse (hazard ratio) Death (hazard ratio)
N 301 378 388 370 378
 Point estimate 1.49 1.18 2.46 0.58 0.81
95% CI 0.65–3.47 0.50–2.79 0.87–6.92 0.28–1.21 0.31–2.13
p-Value 0.3459 0.7113 0.0894 0.1456 0.6757